Benzinga | Mar 30, 2021 04:12PM EDT

Bellicum Pharmaceuticals Q4 EPS $0.98 Beats $(1.06) Estimate

Bellicum Pharmaceuticals (NASDAQ:BLCM) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimate of $(1.06) by 192.45 percent. This is a 116.84 percent increase over losses of $(5.82) per share from the same period last year.